Price $1.79 |
Market Cap
13.4M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
0.89
|
P/S
-
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
-
|
Op. Cash Flow
-5.7K
|
FCF
-0.5
|
|
Op. Margin
-
|
Net Margin
-
|
ROE
-46.10%
|
ROI
-
|
|
ROA
-44.10%
|
EPS Growth
-5.00%
|
Current Ratio
16.8
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Rigel Pharmaceuticals Inc (RIGL) | $13.41 | - | - | 139.2M | Strong Buy |
| ATI Physical Therapy Inc (ATIP) | $6.00 | - | - | 30.8M | Strong Buy |
| PetIQ Inc (PETQ) | $30.58 | - | - | 564.3M | Strong Buy |
| Navidea Biopharmaceuticals Inc (NAVB) | $0.00 | - | - | 5M | Strong Buy |
| Sonoma Pharmaceuticals Inc (SNOA) | $3.16 | - | - | 2.3M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
